Supercharge Your Innovation With Domain-Expert AI Agents!

HER3 antigen binding proteins binding to the beta-hairpin of HER3

A protein-binding technology, HVR-H2, is applied in the field of anti-HER3 antigen-binding protein, which can solve problems that have not yet been fully characterized

Active Publication Date: 2015-07-01
F HOFFMANN LA ROCHE & CO AG
View PDF138 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Additional splice variants have also been reported, but they have not been fully characterized

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HER3 antigen binding proteins binding to the beta-hairpin of HER3
  • HER3 antigen binding proteins binding to the beta-hairpin of HER3
  • HER3 antigen binding proteins binding to the beta-hairpin of HER3

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0596] 1. A method for selecting an antigen-binding protein that binds to human HER3 (and does not cross-react with human HER4), wherein the antigen-binding protein binds within the amino acid sequence PQPLVYNKLTFQLEPNPHT (SEQ ID NO: 1) of human HER3,

[0597] Which uses

[0598] a) at least one polypeptide comprising the amino acid sequence of SEQ ID NO: 1 selected from the group consisting of:

[0599]

[0600] and

[0601] b) at least one polypeptide comprising the amino acid sequence of SEQ ID NO:2 selected from the group consisting of:

[0602]

[0603] to select an antigen binding protein that exhibits binding to at least one polypeptide under a) and exhibits non-binding to at least one polypeptide under b),

[0604] And thus select an antigen-binding protein that binds within the amino acid sequence PQPLVYNKLTFQLEPNPHT (SEQ ID NO: 1) of human HER3 and does not cross-react with human HER4.

[0605] 2. The antigen-binding protein obtained by the selection method ...

Embodiment 1

[0713] Antigen and Screening Protein Preparation - Generation of functional β-hairpin HER3 and β-hairpin HER4 constructs for selection of antibodies that bind HER3 β-hairpin and HER4 β-hairpin

[0714] To generate functional β-hairpin HER3 and HER4 constructs, the amino acid sequences of the β-hairpins of HER3 (SEQ ID NO: 1 ) and HER4 (SEQ ID NO: 2) were grafted into the SlyD polypeptide framework containing the FKBP domain. In such constructs, the grafted β-hairpin is freely accessible, in contrast to the hidden structure in the native unactivated conformation of HER3 or HER4 (in the absence of a ligand such as HRG) (see figure 1 c and 1d, where the β-hairpin of HER3 is hidden).

[0715]All fusion SlyD polypeptides can be purified and refolded using almost the same protocol. Escherichia coli BL21(DE3) cells transformed with specific expression plasmids were grown at 37°C in LB medium containing corresponding antibiotics for selective growth (kanamycin 30 μg / ml, or ampicillin...

Embodiment 2

[0725] a) Immunization and selection of HER3 antibody

[0726] To generate antibodies against the HER3 β-hairpin, Balb / C, NMRI or SJL mice were immunized with different antigens. The following proteins were used as antigens: full-length HER3 ECD, or epitope scaffold proteins TtSlyD-FKBP12-Her3, TtSlyDcys-Her3, TtSlyDcas-Her3, TgSlyDcys-Her3 and TgSlyDser-Her3. The TtSlyD-FKBP12-Her3 variant represents the first epitope scaffold for generating HER3 dimerization domain-specific antibodies. Although the general rationale for using SlyD variants as epitope scaffolds could have been demonstrated earlier using the first generation SlyD-FKBP12 scaffolds, improved scaffold variants with higher stability were developed. These SlyD variants were derived from Thermus thermophilus and Thermus gamma-resistant.

[0727] All mice were immunized three times at time points 0, 6 and 10 weeks after the start of the immunization campaign. At each time point each mouse was immunized with 100 μg...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to anti-HER3 antigen binding proteins, e.g. anti-HER3 antibodies, that bind to the beta-hairpin of HER3, methods for selecting these antigen binding proteins, their preparation and use as medicament.

Description

[0001] The present invention relates to anti-HER3 antigen binding proteins (eg, anti-HER3 antibodies) that bind to the HER3 beta-hairpin, methods for selecting these antigen binding proteins, their preparation and use as medicaments. Background of the invention [0002] The HER protein family consists of 4 members: HER1, also known as epidermal growth factor receptor (EGFR) or ErbB-1; HER2, also known as ErbB-2; ErbB-3, also known as HER3; and ErbB-4, Also known as HER4. ErbB family proteins are receptor tyrosine kinases and represent important mediators of cell growth, differentiation and survival. The HER family of proteins represents receptors for different ligands like the neuregulin (NRG) family, amphiregulin, EGF and TGF-a. Heregulin (also known as HRG or neuregulin NRG-1) is a ligand for eg HER3 and HER4. [0003] Human HER3 (ErbB-3, ERBB3, c-erbB-3, c-erbB3, receptor tyrosine protein kinase erbB-3, SEQ ID NO:3) encodes the epidermal growth factor receptor ( EGFR) fa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/32A61K47/48C07K14/195C07K14/705
CPCC07K2317/92C07K14/71C07K2317/77C07K2319/00C07K16/32C07K2317/70C07K2317/34C07K2317/76C07K2319/70C07K16/2863C07K2317/24A61K47/48569C07K2319/55C07K14/195A61K47/48438C07K2317/55A61K47/6817A61K47/6851A61P35/00A61P35/02A61P43/00A61K47/6803A61K47/6855
Inventor B·博森迈尔D·卡萨戈尔达瓦尔里贝拉G·乔治斯M·格戈G·尼德费尔纳C·肖尔茨M·施拉姆尔
Owner F HOFFMANN LA ROCHE & CO AG
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com